rlliacex | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/rlliacex_hasAnnotation_C0001483> <https://research.tib.eu/covid-19/entity/rlliacex_hasAnnotation_C1418948>
?:creator	<https://research.tib.eu/covid-19/entity/Kremer%2C_Eric_J.>
?:doi	10.1016/j.ymthe.2020.10.002
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.ymthe.2020.10.002>
?:journal	Mol_Ther
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/658a10fbe889a455fbfa2f8abc2af6bc43c0c418.json
?:pmc_json_files	document_parses/pmc_json/PMC7546260.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7546260>
?:pmid	<https://research.tib.eu/covid-19/entity/33065038.0>
?:pmid	33065038.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/658a10fbe889a455fbfa2f8abc2af6bc43c0c418>
?:source	Elsevier; Medline; PMC
?:title	Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-09

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/rlliacex>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/rlliacex>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all